RA Associated With Higher Risk of COPD Hospitalization

Risk is 47 percent higher in RA patients than general population after adjustment for confounders
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Pulmonology, Rheumatology, Journal, Source Type: news

Related Links:

Publication date: Available online 22 October 2018Source: Pulmonary Pharmacology &TherapeuticsAuthor(s): Paulette W. Andreotta, Steve Arold, Jennifer Kenyon, Diane Spicer, Paul Woodman, Elizabeth Berry, Tim Brogan, Sophanna Kong, Pamela Okerholm, Vince Russell, Robert W. Clarke, David L. HavaAbstractTobacco smoke-induced lung inflammation in patients with chronic obstructive pulmonary disease (COPD) worsens with disease progression and acute exacerbations caused by respiratory infections. Chronic therapies to manage COPD center on bronchodilators to improve lung function and inhaled corticosteroids (ICS) to help reduce...
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
This study examines the effects of the reform on adverse events, defined as deaths or readmissions occurring within 60 days of hospitalization.Methods: We use Norwegian register data for patients (age 18+) hospitalized between 2009 and 2014 for COPD/asthma (N=25,936), heart failure (N=27,708), hip fracture (N=44,981) and stroke (N=43,313). Our logit models test for conditional effects of the reform, whereby associations between the reform and adverse events vary by whether or not patients were classified as ready for discharge and in need of follow-up care in the community. The models include fixed effects for districts an...
Source: International Journal of Integrated Care - Category: Nursing Source Type: research
Conclusion: The exclusive use of administrative data would have lead our healthcare system down a misleading path of allocating resources to better management and integration of chronic diseases between primary, acute and specialty care.   Instead, by adding social variables as well as patient/provider narratives to our planning, a completely different emphasis resulted: strengthening primary care and enhancing social supports in the community.  Published on 2018-10-23 00:00:00
Source: International Journal of Integrated Care - Category: Nursing Source Type: research
AbstractChronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide, and long-term oxygen therapy has been shown to reduce mortality in COPD patients with severe hypoxemia. However, the Long-term Oxygen Treatment Trial (LOTT), a large randomized trial, found no benefit of oxygen therapy in COPD patients with moderate hypoxemia. We hypothesized that there may be differences in response to oxygen which depend on genotype or gene expression. In a genome-wide time-to-event analysis of the primary outcome of death or hospitalization in 331 subjects, 97 single nucleotide polymorphisms (SNPs) showed evidenc...
Source: Journal of Molecular Medicine - Category: Molecular Biology Source Type: research
Journal of Magnetic Resonance Imaging, EarlyView.
Source: Journal of Magnetic Resonance Imaging - Category: Radiology Authors: Source Type: research
BOSTON (CBS) – Last week, Canada became the second country to legalize marijuana, but now Canadian scientists say more research is needed to know whether smoking pot is harmful to the lungs. While many tout the drug’s medicinal uses, some experts think those benefits have been overstated and that the potential harms have been understated. Marijuana is similar to tobacco except that it contains THC which causes the “high”. Some studies have suggested smoking the drug can cause respiratory symptoms and lung inflammation but what about long-term use? Can smoking marijuana cause lung cancer and chronic ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Healthwatch Dr. Mallika Marshall Marijuana Source Type: news
Vapotherm last week registered for an initial public offering worth nearly $58 million for the respiratory device it’s developing. Exeter, N.H.-based Vapotherm developed the Precision Flow line of devices to provide high-velocity heated, humidified and oxygenated air to treat patients with conditions such as pneumonia, chronic obstructive pulmonary disease, asthma and heart failure. Some 1,200 of the devices have been sold in the U.S., mostly into hospital ICUs, the company said. In an Oct. 19 filing with the U.S. Securities &Exchange Commission, Vapotherm said the proceeds from the $57.5 million offering ar...
Source: Mass Device - Category: Medical Devices Authors: Tags: Featured Funding Roundup Respiratory Wall Street Beat Vapotherm Source Type: news
Conditions:   Adult;   Risk Factors;   Primary Care;   COPD;   Screening Score;   Spirometry;   Diagnosis Intervention:   Diagnostic Test: PUMA Score questionnaire Sponsors:   Gustavo Zabert, MD;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Objective: To determine if chronic obstructive pulmonary disease (COPD) has an impact on postoperative outcomes and complications following laparoscopic hysterectomy.
Source: The Journal of Minimally Invasive Gynecology - Category: OBGYN Authors: Source Type: research
This study examines the effects of the reform on adverse events, defined as deaths or readmissions occurring within 60 days of hospitalization.Methods: We use Norwegian register data for patients (age 18+) hospitalized between 2009 and 2014 for COPD/asthma (N=25,936), heart failure (N=27,708), hip fracture (N=44,981) and stroke (N=43,313). Our logit models test for conditional effects of the reform, whereby associations between the reform and adverse events vary by whether or not patients were classified as ready for discharge and in need of follow-up care in the community. The models include fixed effects for districts an...
Source: International Journal of Integrated Care - Category: Nursing Source Type: research
More News: Chronic Obstructive Pulmonary | Internal Medicine | Respiratory Medicine | Rheumatology